当前位置: X-MOL 学术Prostate › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer
The Prostate ( IF 2.8 ) Pub Date : 2021-06-14 , DOI: 10.1002/pros.24180
Caroline E Nunes-Xavier 1, 2 , Wanja Kildal 3 , Andreas Kleppe 3, 4 , Håvard E Danielsen 3, 4, 5 , Håkon Waehre 3 , Roberto Llarena 6 , Gunhild M Maelandsmo 1 , Øystein Fodstad 1, 7 , Rafael Pulido 2, 8 , José I López 2, 9
Affiliation  

Novel immune checkpoint-based immunotherapies may benefit specific groups of prostate cancer patients who are resistant to other treatments.

中文翻译:

免疫检查点 B7-H3 蛋白表达与前列腺癌的不良预后和雄激素受体状态相关

基于免疫检查点的新型免疫疗法可能有益于对其他治疗有抵抗力的特定前列腺癌患者群体。
更新日期:2021-07-20
down
wechat
bug